trial · primary record
Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE
Pancreatic Ductal Adenocarcinoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2028-04 |
| Primary endpoint | Percentage of Participants with Treatment-Emergent Adverse Events (Phase 2A) |
| Registry ID | NCT04111172 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:04.795Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04111172
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.